OQS
MED icon

Occudo Quantitative Strategies’s Medifast MED Stock Holding History

Occudo Quantitative Strategies’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,167
Closed -$233K – 833
2024
Q3 		$233K Sell
12,167
-20,065
-62% -$387K 0.04% 541
2024
Q2 		$703K Buy
32,232
+8,239
+34% +$220K 0.12% 234
2024
Q1 		$919K Buy
+23,993
New +$1.16M 0.16% 181
2023
Q4 		– Sell
-12,125
Closed -$908K – 1040
2023
Q3 		$908K Buy
12,125
+2,048
+20% +$182K 0.12% 295
2023
Q2 		$929K Sell
10,077
-3,207
-24% -$286K 0.1% 359
2023
Q1 		$1.38M Buy
+13,284
New +$1.47M 0.12% 231

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Occudo Quantitative Strategies's MED Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Medifast (MED) in Q4 2024, closing a stake of 12,167 shares — an estimated $233K sold.

Occudo Quantitative Strategies first reported a position in MED in Q1 2023 and held it in 6 quarters. The position peaked at $1.38M in Q1 2023. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,167 Medifast shares in Q4 2024, an estimated $233K.
  • Occudo Quantitative Strategies first reported a position in Medifast in Q1 2023 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Medifast position peaked at $1.38M in Q1 2023.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.